News & Events
A Global Marathon Movement
Nothing captures the work and values of MSIF more that this event and we wanted to share…
Asthma medication could slow brain atrophy in progressive MS
A phase II clinical trial has shown ibudilast, a repurposed asthma medication, can slow down the rate…
Cardiovascular disease linked to brain shrinkage in MS
A new study has shown a link between high blood pressure and heart disease and an increased…
Cyprus MS Association meets to discuss new healthcare plan
Up to 80 members of the association will meet in October to learn about a new national…
Signalling success: Swiss MS Society campaign wins innovation award
The ‘Innovation of the Year’ fundraising award was presented in recognition of the Swiss MS Society’s 2017…
Dutch MS Research Foundation part of EUR 15 million research project
The ‘Immune balance’ partnership unites health charities, the government, scientists and corporate bodies in a joint effort…
MS Research Australia triumphs at national Charity Awards
MS Research Australia has been recognised for ‘Outstanding Achievement’ in the Australian Charity Awards 2018.
Dancing for MS: Portugal’s new awareness campaign
The Portuguese MS Society (SPEM) is calling on people nationwide to raise awareness of MS through dance…
Signs of MS may start five years before diagnosis
Canadian research shows people with MS are more likely than the general population to visit a doctor…
Study suggests improvement in MS employment outcomes
New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown…
Primary progressive MS risk may be linked to genes that cause other brain diseases
Genetic screening of people with primary progressive MS has shown that four rare genetic changes, which are…
‘Rings of fire’: blocking the death of brain cells in MS
A new study that suggests inflammation may lead to the death of brain cells in MS may…